Switch theme
Sign up to access all valuation multiples
Center Laboratories Inc is active in the healthcare sector. The company is engaged in the manufacture and sale of various Western medicines. The segments include: Pharmaceutical Division which includes manufacturing and sales of various Western Medicines; Biotechnology Venture Capital consists Investing in domestic and foreign biotechnology undertakings; Glac segment - Manufacture and sale of probiotic products and others. It geographically operates in Taiwan, China and Others.
1957
200
LTM Revenue n/a
LTM EBITDA n/a
$860M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Center Laboratories has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Center Laboratories achieved revenue of $48.9M and an EBITDA of -$23.6M.
Center Laboratories expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Center Laboratories valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $42.1M | $48.9M | XXX | XXX | XXX |
| Gross Profit | $12.3M | $18.7M | XXX | XXX | XXX |
| Gross Margin | 29% | 38% | XXX | XXX | XXX |
| EBITDA | -$23.1M | -$23.6M | XXX | XXX | XXX |
| EBITDA Margin | -55% | -48% | XXX | XXX | XXX |
| Net Profit | $3.1M | -$30.1M | XXX | XXX | XXX |
| Net Margin | 7% | -62% | XXX | XXX | XXX |
| Net Debt | $80.8M | $118M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Center Laboratories's stock price is TWD 35 (or $1).
Center Laboratories has current market cap of TWD 25.2B (or $760M), and EV of TWD 28.5B (or $860M).
See Center Laboratories trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $860M | $760M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Center Laboratories has market cap of $760M and EV of $860M.
Center Laboratories's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Center Laboratories's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Center Laboratories and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $860M | XXX | XXX | XXX |
| EV/Revenue | 17.6x | XXX | XXX | XXX |
| EV/EBITDA | -36.4x | XXX | XXX | XXX |
| P/E | -22.8x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 121.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpCenter Laboratories's NTM/LTM revenue growth is n/a
Center Laboratories's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Center Laboratories's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Center Laboratories's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Center Laboratories and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 16% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -48% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 2% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 14% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 13% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 32% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Center Laboratories acquired XXX companies to date.
Last acquisition by Center Laboratories was XXXXXXXX, XXXXX XXXXX XXXXXX . Center Laboratories acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Center Laboratories founded? | Center Laboratories was founded in 1957. |
| Where is Center Laboratories headquartered? | Center Laboratories is headquartered in Taiwan. |
| How many employees does Center Laboratories have? | As of today, Center Laboratories has 200 employees. |
| Is Center Laboratories publicy listed? | Yes, Center Laboratories is a public company listed on ROCO. |
| What is the stock symbol of Center Laboratories? | Center Laboratories trades under 4123 ticker. |
| When did Center Laboratories go public? | Center Laboratories went public in 2003. |
| Who are competitors of Center Laboratories? | Similar companies to Center Laboratories include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Center Laboratories? | Center Laboratories's current market cap is $760M |
| What is the current revenue growth of Center Laboratories? | Center Laboratories revenue growth between 2023 and 2024 was 16%. |
| Is Center Laboratories profitable? | Yes, Center Laboratories is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
